These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21909647)

  • 1. The relationship among PDX1, CDX2, and mucin profiles in gastric carcinomas; correlations with clinicopathologic parameters.
    Oz Puyan F; Can N; Ozyilmaz F; Usta U; Sut N; Tastekin E; Altaner S
    J Cancer Res Clin Oncol; 2011 Dec; 137(12):1749-62. PubMed ID: 21909647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of phenotypic expression in undifferentiated-type early gastric adenocarcinomas using mucin core protein and CDX2.
    Ikarashi S; Nishikura K; Ajioka Y; Aoyagi Y
    Gastric Cancer; 2013 Apr; 16(2):208-19. PubMed ID: 22829163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
    Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
    Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas.
    Sakai H; Eishi Y; Li XL; Akiyama Y; Miyake S; Takizawa T; Konishi N; Tatematsu M; Koike M; Yuasa Y
    Gut; 2004 Mar; 53(3):323-30. PubMed ID: 14960508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
    Matsuda K; Yamauchi K; Matsumoto T; Sano K; Yamaoka Y; Ota H
    Scand J Gastroenterol; 2008 Jan; 43(1):25-33. PubMed ID: 18938748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].
    Xiong ZF; Xiao H; Tan YS
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):442-6. PubMed ID: 21055171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
    Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.
    Pinto-de-Sousa J; Reis CA; David L; Pimenta A; Cardoso-de-Oliveira M
    Virchows Arch; 2004 Mar; 444(3):224-30. PubMed ID: 14758553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin-Phenotype and Expression of the Protein V-Set and Immunoglobulin Domain Containing 1 (VSIG1): New Insights into Gastric Carcinogenesis.
    Satala CB; Jung I; Gurzu S
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
    Terada T
    Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
    Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
    Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis.
    Ishikawa A; Sasaki M; Ohira S; Ohta T; Oda K; Nimura Y; Chen MF; Jan YY; Yeh TS; Nakanuma Y
    Lab Invest; 2004 May; 84(5):629-38. PubMed ID: 15048136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer.
    Liu Q; Teh M; Ito K; Shah N; Ito Y; Yeoh KG
    Mod Pathol; 2007 Dec; 20(12):1286-97. PubMed ID: 17906616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.
    Jun SY; Eom DW; Park H; Bae YK; Jang KT; Yu E; Hong SM
    Mod Pathol; 2014 Oct; 27(10):1364-74. PubMed ID: 24603585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
    Gürbüz Y; Kahlke V; Klöppel G
    Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox2 expression in human stomach adenocarcinomas with gastric and gastric-and-intestinal-mixed phenotypes.
    Tsukamoto T; Mizoshita T; Mihara M; Tanaka H; Takenaka Y; Yamamura Y; Nakamura S; Ushijima T; Tatematsu M
    Histopathology; 2005 Jun; 46(6):649-58. PubMed ID: 15910596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas.
    Reis CA; David L; Carvalho F; Mandel U; de Bolós C; Mirgorodskaya E; Clausen H; Sobrinho-Simões M
    J Histochem Cytochem; 2000 Mar; 48(3):377-88. PubMed ID: 10681391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
    Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
    Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
    Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
    Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.